Global and Japan Dronabinol (CAS 1972-08-3) Market Insights, Forecast to 2027

Dronabinol is a form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). THC demonstrates its effects through weak partial agonist activity at Cannabinoid-1 (CB1R) and Cannabinoid-2 (CB2R) receptors, which results in the well-known effects of smoking cannabis such as increased appetite, reduced pain, and changes in emotional and cognitive processes. Due to its evidence as an appetite stimulant and an anti-nauseant, Dronabinol is approved for use in anorexia associated with weight loss in patients with AIDS and for the treatment of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.
In 2019, the global Dronabinol (CAS 1972-08-3) market is led by North America. Europe is the second-largest region-wise market.
Noramco, Canopy Growth, THC Pharm, Echo Pharmaceuticals and Aphios Corporation are the major players in the world, top five manufactures occupied nearly 52% of the revenue market share in 2019.
In terms of types, Purity 99% occupied the largest sales share of about 72% in 2019.

Market Analysis and Insights: Global and Japan Dronabinol (CAS 1972-08-3) Market
This report focuses on global and Japan Dronabinol (CAS 1972-08-3) market.
In 2020, the global Dronabinol (CAS 1972-08-3) market size was US$ 147.2 million and it is expected to reach US$ 200.5 million by the end of 2027, with a CAGR of 4.5% during 2021-2027. In Japan the Dronabinol (CAS 1972-08-3) market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Dronabinol (CAS 1972-08-3) Scope and Market Size
Dronabinol (CAS 1972-08-3) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Dronabinol (CAS 1972-08-3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Dronabinol (CAS 1972-08-3) market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
Purity 98%
Purity 99%

Segment by Application
Capsule
Oral Liquid

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Canopy Growth
Noramco
KinetoChem
Entourage Phytolab
THC Pharm
Echo Pharmaceuticals
BOL Pharma
Aphios Corporation
Benuvia Manufacturing